Rosen & Barkin's 5-Minute Emergency Medicine Consult (187 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
3.28Mb size Format: txt, pdf, ePub
DISPOSITION
Admission Criteria
  • Most affected patients should be admitted to the hospital.
  • ICU admission is required for any instability or cyanosis.
Discharge Criteria

Reversible causes of hypoxia:

  • Reactive airway disease responsive to β-agonists
  • Pulmonary edema in patient with known CHF but no suspicion of myocardial injury and diuresis
PEARLS AND PITFALLS
  • First assume hypoxemia and immediately assess airway and breathing
  • Chocolate-colored blood or unchanging oxygen saturation despite aggressive administration of oxygen: Think methemoglobinemia.
ADDITIONAL READING
  • BheemReddy S, Messineo F, Roychoudhury D. Methemoglobinemia following transesophageal echocardiograph: A case report and review.
    Echocardiography
    . 2006;23(4):319–321.
  • Kurklinsky AK, Miller VM, Rooke TW. Acrocyanosis: The flying Dutchman.
    Vasc Med.
    2011;16(4):288–301.
  • McMullen SM, Patrick W.
    Cyanosis. Am J Med.
    2013;126(3):210–212.
  • LeBlond R, Brown D, DeGowin R.
    DeGowin’s Diagnostic Examination
    . 9th ed. McGraw Hill Companies; 2009.
  • Stack A. Cyanosis.
    Synopsis of Pediatric Emergency Medicine.
    4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:64–67.
CODES
ICD9
  • 770.83 Cyanotic attacks of newborn
  • 782.5 Cyanosis
ICD10
  • P28.2 Cyanotic attacks of newborn
  • R23.0 Cyanosis
CYSTIC FIBROSIS
Joseph Kahn
BASICS
DESCRIPTION
  • Defect of the cystic fibrosis transmembrane conductance regulator (CFTR)
  • CFTR functions as an ATP-regulated chloride channel that regulates the activity of chloride and sodium channels on the cell surface:
    • Abnormal electrolyte transport in exocrine glands and secretory epithelia
    • Decreased exocrine pancreatic function with malabsorption
    • Thickened mucus, recurrent pulmonary infections, and progressive obstructive damage to the lungs
    • Recurrent sinus disease
  • Occurs in 1:3,600 live births in White population, 1:29,000 in African American population; 1:6,500 in Hispanic population
  • 30% of cases diagnosed by newborn screening
  • 75% cases diagnosed in the 1st 2 yr of life
  • ∼30,000 children and young adults in US have CF.
  • Median life expectancy in US about 40 yr.
  • 40% of CF patients are older than 18 yr.
  • 10 million Americans are unknown, asymptomatic carriers of the defective gene.
  • 16% of lung transplants in US due to CF
RISK FACTORS
Genetics

Recessively inherited genetic disease, involving the CFTR gene on the long arm of chromosome 7:

  • Different mutations; variable phenotypes.
  • Classic disease: Homozygous DF508 mutation.
  • Most common lethal genetic disease in US
ETIOLOGY

Common organisms in patients with pneumonia; often multiple drug resistance:

  • Staphylococcus aureus:
    • MSSA/MRSA
  • Pseudomonas aeruginosa:
    • Prevalence increases with age; >70% of adults are chronically infected.
  • Haemophilus influenzae
  • Stenotrophomonas maltophilia
  • Burkholderia cepacia:
    • Prevalence 3%
    • Associated with rapid clinical deterioration
  • Achromobacter xylosoxidans
  • Mycobacteria (nontuberculous):
    • Mycobacterium avium
      complex,
      Mycobacterium abscessus
  • Aspergillus
DIAGNOSIS
SIGNS AND SYMPTOMS
  • General:
    • Failure to thrive
    • Recurrent respiratory tract infections
    • Anasarca in infancy
    • Salty taste of skin
  • Head, ears, eyes, nose, and throat (HEENT):
    • Nasal polyps; severe headaches due to sinusitis; otitis media
  • Pulmonary:
    • Persistent cough. Initially dry, then productive
    • Recurrent pneumonitis or bronchiolitis in 1st yr of life
    • Wheezing
    • Hemoptysis
    • Pneumonia
    • Chronic bronchitis
    • Bronchiectasis
    • Respiratory distress
    • Pneumothorax
    • Pneumomediastinum
    • Most common cause of CF hospitalization
  • Cardiac:
    • CHF
    • Cor pulmonale; pulmonary hypertension
  • GI:
    • Abdominal pain
    • Meconium ileus
    • Distal intestinal obstructive syndrome (DIOS) or “meconium ileus equivalent”
    • Gastroesophageal reflux
    • Cholelithiasis
    • Pancreatitis/pancreatic insufficiency
    • Ileocecal intussusception
    • Foul smelling, fatty stools
    • Jaundice/cirrhosis
    • Rectal prolapse
    • Hematemesis
    • Small intestine bacterial overgrowth
  • Extremities:
    • Bone pain
    • Edema/joint effusions
    • Decreased thickness of cortical bone
  • Recurrent venous thrombosis
  • Cardiorespiratory failure is most common cause of death.
ESSENTIAL WORKUP
  • Sweat chloride test
  • DNA analysis if sweat test equivocal
  • Nasal potential difference if DNA inconclusive
DIAGNOSIS TESTS & NTERPRETATION
Lab
  • Sweat chloride test:
    • Chloride concentration >60 mEq/L
    • With classic signs and symptoms, a positive test result confirms the diagnosis.
  • Stool sample:
    • Decreased elastase, trypsin, or chymotrypsin
    • Increased fat in 72-hr fecal fat excretion
  • Immunoreactive trypsin (IRT):
    • Defines increased risk and/or diagnosis
    • May be falsely positive or negative
  • DNA analysis:
    • Indicated if symptoms are highly suggestive, but sweat test result is negative
    • 90% of CF chromosomes identified
    • Positive if 2 abnormal genes present
    • Genotyping cannot establish the diagnosis.
    • 1,300 CTFR mutations listed
    • Ameliorating or neutralizing 2nd mutation may be present.
  • CBC:
    • Thrombocytopenia
  • Serum electrolytes:
    • Hyponatremic, hypochloremic alkalosis
  • Serum glucose:
    • Hyperglycemia and new-onset diabetes in adolescents and adults; ketoacidosis is rare.
  • Liver function tests and PT:
    • Obtain if hematemesis or hemoptysis or signs of liver failure
  • ABG:
    • Hypoxemia. Metabolic alkalosis
  • Sputum culture:
    • May have pseudomonal colonization.
  • Studies indicated in high-risk patients with unclear diagnosis:
    • Nasal potential-difference measurements:
      • Complex and time-consuming study
    • Semen analysis:
      • Azoospermia
Imaging
  • Chest radiograph:
    • Hyperaeration
    • Peribronchial thickening
    • Atelectasis
    • Hilar lymphadenopathy
    • Pneumothorax/pneumomediastinum
    • Bronchiectasis
    • Blebs
    • Chest CT identifies blebs/bronchiectasis
  • Abdominal radiographs and/or CT:
    • Indicated if abdominal pain, vomiting, or abdominal distention
    • Distal intestinal obstruction syndrome
    • Intussusception
  • Barium enema:
    • Indicated if suspicion of intussusception
  • Sinus films:
    • Limited use because routine sinus films are always cloudy
    • CT scan is needed to assess sinuses for pre-operative planning.
Diagnostic Procedures/Surgery

Bronchoalveolar lavage:

  • High percentage of neutrophils and absolute neutrophil count
  • Unnecessary if obvious pulmonary symptoms
DIFFERENTIAL DIAGNOSIS
  • Respiratory:
    • Asthma
    • Recurrent pneumonia
    • Bronchiectasis
    • Pertussis
    • Immunodeficiency
    • Foreign body aspiration
    • α
      1
      -Antitrypsin deficiency
    • Ciliary agenesis
  • GI:
    • Chronic diarrhea
    • Gastroenteritis
    • Milk allergy
  • Elevated electrolyte levels in sweat:
    • Fucosidosis
    • Glycogen storage disease type I
    • Mucopolysaccharidosis
    • Hypothyroidism
    • Vasopressin-resistant diabetes insipidus
    • Adrenal insufficiency
    • Familial cholestasis
    • Familial hypoparathyroidism
    • Malnutrition
    • Ectodermal dysplasia
    • Atopic dermatitis
    • Infusion of prostaglandin E
      1
TREATMENT

Other books

The Homework Machine by Dan Gutman
Let Me Be Your Star by Rachel Shukert
All She Ever Wanted by Rosalind Noonan
Tested by the Night by Maxine Mansfield
Sinful Desires Vol. 5 by M. S. Parker
The Last Passenger by Manel Loureiro